Professional
Added to YB: 2024-02-16
Pitch date: 2024-02-14
CYRX [neutral]
Cryoport, Inc.
-41.69%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
Market Cap
$500.2M
Pitch Price
$16.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
-37.27
P/E
-8.23
EV/Sales
1.44
Sector
Life Sciences Tools and Services
Category
growth
Pernas Research: Cryoport - $CYRX
CYRX: Leader in cryo solutions for booming cell & gene therapy market (15% CAGR). Trades at 5x sales despite no profits. Buybacks at 3x current price concerning. Waiting for further pullback before considering a position in this "IBM of temp-controlled solutions".
Read full article (1 min)